dc.contributor.author
Fleckenstein, Florian Nima
dc.contributor.author
Jonczyk, Martin
dc.contributor.author
Can, Elif
dc.contributor.author
Lüdemann, Willie Magnus
dc.contributor.author
Savic, Lynn Jeanette
dc.contributor.author
Maleitzke, Tazio
dc.contributor.author
Krenzien, Felix
dc.contributor.author
Gebauer, Bernhard
dc.date.accessioned
2023-03-13T16:50:10Z
dc.date.available
2023-03-13T16:50:10Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/38352
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-38071
dc.description.abstract
The presented report describes a case of a Hepatocellular carcinoma (HCC) tumor thrombus (TT) infiltrating the inferior vena cava (IVC) and the right atrium (RA) in a 66-year old male patient who initially presented with TT related symptoms. CT-guided high-dose-rate brachytherapy (HDRBT) was performed for both, the intraparenchymal primary and the TT. A marked improvement of the tumor-related symptoms and shrinkage of the tumor mass were achieved six months after treatment initiation. The combination of intravascular and percutaneous HDRBT demonstrating a promising approach to palliate tumor-related symptoms in advanced HCC with macrovascular invasion.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Advanced HCC
en
dc.subject
locoregional therapy
en
dc.subject
transvascular treatment
en
dc.subject
brachytherapy
en
dc.subject
atrial tumor invasion
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Hepatocellular carcinoma tumor thrombus entering the right atrium treated with combining percutaneous and intravenous high-dose-rate brachytherapy: a case report
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
71
dcterms.bibliographicCitation.doi
10.1186/s42155-021-00259-x
dcterms.bibliographicCitation.journaltitle
CVIR Endovascular
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.volume
4
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
34618268
dcterms.isPartOf.eissn
2520-8934